Nifty

:

25461.00

Sensex

:

83432.89

55.70 (0.22%)
193.42 (0.23%)

Login

Nifty
Sensex

:
:

25461.00
83432.89

55.70 (0.22%)
193.42 (0.23%)

Jupiter Life Line Hospitals Ltd.

Hospital & Healthcare Services

Rating :

67/99

BSE: 543980 | NSE: JLHL

Watchlist

NSE BSE

1506.50

04-Jul-2025

Open
High
Low
Previous Close

1499.9
1514.4
1474
1490.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

37488
56171668.3
1770
1248.95

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

9,893.26
51.44
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

9,730.30
0.07%
7.29

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.52
-
12.23

EBITDA CAGR (%)

10 Years
5 Years
3 Years

15.97
-
8.06

PAT CAGR (%)

10 Years
5 Years
3 Years

19.51
-
38.45

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 28.68 29.47 34.58 40.17
P/E Ratio 52.53 51.12 43.57 37.50
Revenue 1070 1262 1457 1731
EBITDA 238 297 355 414
Net Income 177 193 231 263
ROA 15.6 12.1
P/B Ratio 7.93 7.28 6.26 5.38
ROE 23.02 15.3 15.1 15.07
FCFF 26 -55 43 56
FCFF Yield 0.29 -0.6 0.47 0.61
Net Debt -318 -210 -375 -517
BVPS 189.92 206.85 240.74 280.07

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 273.91 246.12 11.29% 269.13 230.38 16.82% 273.10 227.07 20.27% 239.41 207.87 15.17%
Expenses 201.70 188.93 6.76% 201.69 173.33 16.36% 203.66 168.27 21.03% 183.73 156.74 17.22%
EBITDA 72.21 57.19 26.26% 67.44 57.05 18.21% 69.45 58.80 18.11% 55.68 51.14 8.88%
EBIDTM 26.36% 23.24% 25.06% 24.76% 25.43% 25.89% 23.26% 24.60%
Other Income 6.95 7.94 -12.47% 8.13 7.92 2.65% 9.26 6.17 50.08% 8.24 6.79 21.35%
Interest 4.00 0.93 330.11% 2.65 1.01 162.38% 1.00 8.51 -88.25% 0.95 8.21 -88.43%
Depreciation 13.38 7.47 79.12% 10.64 7.65 39.08% 10.41 7.65 36.08% 7.98 7.75 2.97%
PBT 61.78 59.01 4.69% 62.28 56.16 10.90% 67.29 48.04 40.07% 54.99 40.61 35.41%
Tax 17.33 15.87 9.20% 12.97 13.93 -6.89% 16.99 11.91 42.65% 14.34 10.17 41.00%
PAT 44.45 43.15 3.01% 49.31 42.23 16.77% 50.30 36.13 39.22% 40.65 30.44 33.54%
PATM 16.23% 17.53% 18.32% 18.33% 18.42% 15.91% 16.98% 14.64%
EPS 6.78 6.58 3.04% 7.52 6.44 16.77% 7.67 5.51 39.20% 6.20 4.64 33.62%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 326.74 291.38 12.14% 320.64 272.61 17.62% 322.58 263.18 22.57% 287.13 243.22 18.05%
Expenses 248.49 228.21 8.89% 245.63 210.76 16.54% 247.59 202.15 22.48% 223.27 190.23 17.37%
EBITDA 78.25 63.17 23.87% 75.01 61.85 21.28% 74.99 61.03 22.87% 63.85 53.00 20.47%
EBIDTM 23.95% 21.68% 23.39% 22.69% 23.25% 23.19% 22.24% 21.79%
Other Income 7.03 8.06 -12.78% 8.30 8.06 2.98% 9.44 3.96 138.38% 8.37 5.01 67.07%
Interest 5.57 0.93 498.92% 2.78 1.03 169.90% 1.12 12.23 -90.84% 1.08 12.16 -91.12%
Depreciation 17.62 10.39 69.59% 13.97 10.65 31.17% 14.40 10.62 35.59% 11.00 10.72 2.61%
PBT 62.10 62.20 -0.16% 66.55 58.08 14.58% 68.91 41.37 66.57% 60.14 33.76 78.14%
Tax 17.22 16.93 1.71% 14.04 14.42 -2.64% 17.40 7.69 126.27% 15.54 -20.24 -
PAT 44.87 45.27 -0.88% 52.51 43.67 20.24% 51.51 33.68 52.94% 44.61 54.00 -17.39%
PATM 13.73% 15.53% 16.38% 16.02% 15.97% 12.80% 15.54% 22.20%
EPS 6.84 6.87 -0.44% 8.01 6.66 20.27% 7.86 5.14 52.92% 6.80 9.55 -28.80%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales - 1,060.00 914.57 787.32 657.28 250.51 221.63 185.77 155.28 130.99 Net Sales Growth - 15.90% 16.16% 19.78% 162.38% 13.03% 19.30% 19.64% 18.54% Cost Of Goods Sold - 191.18 158.73 134.90 126.65 48.84 44.10 40.54 37.66 35.69 Gross Profit - 868.82 755.84 652.42 530.63 201.67 177.54 145.23 117.62 95.30 GP Margin - 81.96% 82.64% 82.87% 80.73% 80.50% 80.11% 78.18% 75.75% 72.75% Total Expenditure - 790.78 687.26 583.29 498.43 189.35 161.11 145.15 126.84 107.99 Power & Fuel Cost - 20.60 16.86 16.45 13.77 9.89 7.90 8.01 8.75 5.67 % Of Sales - 1.94% 1.84% 2.09% 2.09% 3.95% 3.56% 4.31% 5.63% 4.33% Employee Cost - 177.22 158.61 129.48 113.90 36.73 31.04 26.16 22.63 17.69 % Of Sales - 16.72% 17.34% 16.45% 17.33% 14.66% 14.01% 14.08% 14.57% 13.50% Manufacturing Exp. - 88.94 78.33 72.69 59.90 2.39 1.61 1.92 2.33 1.73 % Of Sales - 8.39% 8.56% 9.23% 9.11% 0.95% 0.73% 1.03% 1.50% 1.32% General & Admin Exp. - 287.18 253.40 227.20 173.06 62.05 53.22 45.69 36.99 29.04 % Of Sales - 27.09% 27.71% 28.86% 26.33% 24.77% 24.01% 24.59% 23.82% 22.17% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 25.66 21.34 2.56 11.15 29.46 23.26 22.83 18.48 18.17 % Of Sales - 2.42% 2.33% 0.33% 1.70% 11.76% 10.49% 12.29% 11.90% 13.87% EBITDA - 269.22 227.31 204.03 158.85 61.16 60.52 40.62 28.44 23.00 EBITDA Margin - 25.40% 24.85% 25.91% 24.17% 24.41% 27.31% 21.87% 18.32% 17.56% Other Income - 28.14 25.69 13.29 3.75 2.30 2.23 1.06 1.21 1.07 Interest - 8.61 18.66 27.71 29.23 7.69 9.63 12.05 14.21 13.32 Depreciation - 42.41 30.52 28.61 27.66 10.72 10.31 8.60 8.31 7.28 PBT - 246.34 203.82 161.01 105.71 45.05 42.80 21.03 7.14 3.47 Tax - 61.64 51.87 51.67 21.04 13.97 10.16 4.63 0.81 1.13 Tax Rate - 25.02% 25.45% 32.52% 19.90% 31.01% 23.74% 22.02% 11.34% 32.56% PAT - 184.70 151.95 107.21 84.67 31.07 32.65 16.40 6.33 2.34 PAT before Minority Interest - 184.70 151.95 107.21 84.67 31.07 32.65 16.40 6.33 2.34 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 17.42% 16.61% 13.62% 12.88% 12.40% 14.73% 8.83% 4.08% 1.79% PAT Growth - 21.55% 41.73% 26.62% 172.51% -4.84% 99.09% 159.08% 170.51% EPS - 28.16 23.16 16.34 12.91 4.74 4.98 2.50 0.96 0.36

Description TTM Mar 25 Mar 24 Mar 23 Mar 22
Net Sales - 1,261.55 1,073.44 892.54 733.12 Net Sales Growth - 17.52% 20.27% 21.75% Cost Of Goods Sold - 230.16 189.47 157.18 142.22 Gross Profit - 1,031.38 883.97 735.36 590.90 GP Margin - 81.75% 82.35% 82.39% 80.60% Total Expenditure - 964.98 831.34 691.22 579.74 Power & Fuel Cost - 24.28 21.40 20.86 13.77 % Of Sales - 1.92% 1.99% 2.34% 1.88% Employee Cost - 214.50 189.94 151.50 128.98 % Of Sales - 17.00% 17.69% 16.97% 17.59% Manufacturing Exp. - 107.28 91.84 80.55 68.41 % Of Sales - 8.50% 8.56% 9.02% 9.33% General & Admin Exp. - 356.72 313.25 278.57 210.68 % Of Sales - 28.28% 29.18% 31.21% 28.74% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% Miscellaneous Exp. - 32.04 25.45 2.56 15.67 % Of Sales - 2.54% 2.37% 0.29% 2.14% EBITDA - 296.57 242.10 201.32 153.38 EBITDA Margin - 23.51% 22.55% 22.56% 20.92% Other Income - 28.68 22.05 10.42 4.02 Interest - 10.55 26.34 42.27 43.94 Depreciation - 56.98 42.38 38.55 36.16 PBT - 257.70 195.41 130.91 77.32 Tax - 64.20 18.80 55.80 25.99 Tax Rate - 24.91% 9.62% 43.35% 33.70% PAT - 193.50 176.61 72.91 51.13 PAT before Minority Interest - 193.50 176.61 72.91 51.13 Minority Interest - 0.00 0.00 0.00 0.00 PAT Margin - 15.34% 16.45% 8.17% 6.97% PAT Growth - 9.56% 142.23% 42.60% EPS - 29.50 26.92 11.11 7.79

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 14 Mar 13 Mar 12
Shareholder's Funds 1,422.54 1,245.26 465.02 328.87 75.93 61.93 55.36 Share Capital 65.57 65.57 56.52 50.87 46.30 46.11 45.94 Total Reserves 1,356.98 1,179.69 408.51 276.22 29.63 15.83 9.41 Non-Current Liabilities 166.23 27.04 319.69 322.57 52.05 58.43 65.15 Secured Loans 74.25 0.00 294.69 297.88 46.45 54.33 61.18 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 3.88 2.21 0.00 0.00 0.00 0.00 0.00 Current Liabilities 121.57 88.30 100.62 103.30 65.65 74.52 69.43 Trade Payables 82.16 50.54 62.44 53.62 20.95 28.99 30.35 Other Current Liabilities 26.80 19.05 18.42 12.95 10.64 15.42 11.83 Short Term Borrowings 0.00 0.00 0.04 21.24 24.19 26.34 23.78 Short Term Provisions 12.62 18.71 19.73 15.49 9.86 3.77 3.47 Total Liabilities 1,710.34 1,360.60 885.33 754.74 193.63 194.88 189.94 Net Block 713.20 477.32 476.47 464.58 155.67 157.06 154.43 Gross Block 977.04 731.32 700.07 660.06 195.92 188.70 177.77 Accumulated Depreciation 263.84 254.00 223.60 195.47 40.25 31.65 23.34 Non Current Assets 1,044.46 976.88 688.50 578.43 164.92 165.94 165.73 Capital Work in Progress 162.56 61.10 16.24 13.86 8.52 5.75 8.91 Non Current Investment 94.03 94.03 94.04 68.13 0.72 3.11 2.29 Long Term Loans & Adv. 73.39 326.97 85.37 29.07 0.00 0.00 0.00 Other Non Current Assets 1.28 17.45 16.37 2.78 0.00 0.02 0.09 Current Assets 665.88 383.72 196.84 176.32 28.72 28.95 24.21 Current Investments 114.27 16.87 1.40 2.73 0.00 0.00 0.00 Inventories 18.17 16.77 15.49 13.29 5.12 4.14 4.55 Sundry Debtors 36.56 46.35 40.02 27.65 8.38 11.99 9.45 Cash & Bank 487.76 297.19 133.31 102.16 1.30 2.27 2.97 Other Current Assets 9.12 4.56 4.18 2.39 13.92 10.56 7.24 Short Term Loans & Adv. 1.12 1.98 2.44 28.09 0.25 0.53 0.61 Net Current Assets 544.30 295.42 96.22 73.02 -36.93 -45.57 -45.23 Total Assets 1,710.34 1,360.60 885.34 754.75 193.64 194.89 189.94

Description Mar 25 Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,356.24 1,169.04 365.69 293.55 Share Capital 65.57 65.57 56.52 50.87 Total Reserves 1,290.68 1,103.47 309.17 240.90 Non-Current Liabilities 396.21 6.84 489.49 497.06 Secured Loans 321.75 0.00 452.51 463.27 Unsecured Loans 0.00 0.00 0.00 1.25 Long Term Provisions 4.97 3.10 0.00 0.00 Current Liabilities 152.43 105.75 132.14 123.20 Trade Payables 102.91 62.24 70.73 61.11 Other Current Liabilities 33.19 22.69 29.43 19.05 Short Term Borrowings 0.71 0.00 4.73 23.07 Short Term Provisions 15.62 20.82 27.25 19.97 Total Liabilities 1,904.88 1,281.33 985.55 908.69 Net Block 977.40 717.63 719.70 683.91 Gross Block 1,289.20 1,005.29 965.10 891.24 Accumulated Depreciation 311.80 287.66 245.40 207.33 Non Current Assets 1,217.84 871.57 776.27 728.26 Capital Work in Progress 185.11 74.00 29.15 26.62 Non Current Investment 0.13 0.14 0.15 0.15 Long Term Loans & Adv. 53.91 57.89 6.70 10.78 Other Non Current Assets 1.28 21.90 20.58 6.80 Current Assets 687.05 409.76 209.26 180.44 Current Investments 114.27 16.87 1.40 2.73 Inventories 24.10 21.34 19.00 15.36 Sundry Debtors 41.89 57.21 45.69 27.87 Cash & Bank 488.67 301.25 134.46 103.37 Other Current Assets 18.13 5.78 4.91 2.75 Short Term Loans & Adv. 7.49 7.32 3.80 28.37 Net Current Assets 534.62 304.01 77.12 57.24 Total Assets 1,904.89 1,281.33 985.53 908.70

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 219.88 109.79 184.03 142.34 34.16 21.91 34.59 PBT 246.34 203.82 158.88 105.71 21.03 7.14 3.47 Adjustment 23.98 24.97 48.65 53.95 21.50 21.50 19.24 Changes in Working Capital 11.94 -69.32 9.80 -8.69 -3.64 -6.05 12.17 Cash after chg. in Working capital 282.27 159.47 217.33 150.97 38.89 22.59 34.88 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -62.39 -49.68 -33.30 -8.62 -4.73 -0.68 -0.28 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -173.29 -238.04 -129.66 -68.92 -10.74 -7.50 -43.66 Net Fixed Assets -347.18 -76.11 -42.39 -469.48 -9.99 -7.77 Net Investments -97.40 -15.46 -24.58 -70.14 2.39 -0.82 Others 271.29 -146.47 -62.69 470.70 -3.14 1.09 Cash from Financing Activity 301.84 121.88 -23.23 9.66 -24.38 -15.11 10.92 Net Cash Inflow / Outflow 348.43 -6.36 31.15 83.08 -0.96 -0.70 1.85 Opening Cash & Equivalents 18.98 25.34 102.16 18.46 2.27 2.97 1.12 Closing Cash & Equivalent 367.41 18.98 133.31 102.16 1.30 2.27 2.97

Description Mar 25 Mar 24 Mar 23 Mar 22
Cash From Operating Activity 253.30 114.52 117.17 136.97 PBT 257.70 195.41 128.71 77.12 Adjustment 42.98 49.70 76.00 77.08 Changes in Working Capital 20.06 -80.91 -54.24 -8.60 Cash after chg. in Working capital 320.75 164.20 150.47 145.59 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -67.44 -49.68 -33.30 -8.62 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -208.62 -246.14 -103.57 -85.25 Net Fixed Assets -347.18 -76.11 -42.39 Net Investments -97.40 -15.46 -24.58 Others 235.96 -154.57 -36.60 Cash from Financing Activity 300.63 128.16 17.50 32.20 Net Cash Inflow / Outflow 345.31 -3.47 31.10 83.93 Opening Cash & Equivalents 23.01 26.48 103.37 18.46 Closing Cash & Equivalent 368.32 23.01 134.46 103.37

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 216.96 189.92 82.28 64.30 16.40 13.43 12.05 ROA 12.03% 13.53% 13.07% 12.37% 8.44% 3.29% 1.23% ROE 13.85% 17.77% 27.07% 29.18% 23.80% 10.79% 4.23% ROCE 18.59% 22.16% 26.40% 23.15% 21.34% 13.98% 11.19% Fixed Asset Turnover 1.24 1.28 1.16 1.05 0.97 0.85 0.74 Receivable days 14.27 17.24 15.69 13.35 20.00 25.19 26.32 Inventory Days 6.02 6.44 6.67 6.89 9.10 10.22 12.69 Payable days 126.67 129.90 157.01 148.90 105.76 136.21 159.97 Cash Conversion Cycle -106.38 -106.23 -134.65 -128.65 -76.65 -100.80 -120.97 Total Debt/Equity 0.05 0.00 0.64 0.98 1.04 1.51 1.71 Interest Cover 29.63 11.93 6.73 4.62 2.75 1.50 1.26

Description Mar 25 Mar 24 Mar 23 Mar 22
Book Value (Rs.) 206.85 178.30 64.70 57.36 ROA 12.15% 15.58% 7.70% 6.01% ROE 15.32% 23.02% 22.18% 19.27% ROCE 18.82% 22.14% 21.07% 16.66% Fixed Asset Turnover 1.10 1.09 0.96 0.87 Receivable days 14.34 17.49 15.04 12.37 Inventory Days 6.57 6.86 7.02 7.07 Payable days 130.95 128.08 153.08 153.57 Cash Conversion Cycle -110.04 -103.72 -131.01 -134.13 Total Debt/Equity 0.24 0.00 1.28 1.70 Interest Cover 25.42 8.42 4.04 2.76

Top Investors:

sbi healthcare opportunities fund

jm financial products limited

kamini arvind rao

goldman sachs funds - goldman sachs india equity p

mihir wire industries pvt ltd

dr navin ramji davda

j m financial and investment consultancy services

ramakant jagdish tibrewala

nitin manilal thakker

brijesh ramakant tibrewala

Annual Reports:

News Update:

Jupiter Life Line - Quarterly Results
9th May 2025, 18:26 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback